• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

额颞叶变性综合征中的淡漠与冲动行为

Apathy and impulsivity in frontotemporal lobar degeneration syndromes.

作者信息

Lansdall Claire J, Coyle-Gilchrist Ian T S, Jones P Simon, Vázquez Rodríguez Patricia, Wilcox Alicia, Wehmann Eileen, Dick Katrina M, Robbins Trevor W, Rowe James B

机构信息

Department of Clinical Neurosciences, University of Cambridge, UK.

University Medical Centre Hamburg-Eppendorf, University of Hamburg, Germany.

出版信息

Brain. 2017 Jun 1;140(6):1792-1807. doi: 10.1093/brain/awx101.

DOI:10.1093/brain/awx101
PMID:28486594
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5868210/
Abstract

Apathy and impulsivity are common and disabling consequences of frontotemporal lobar degeneration. They cause substantial carer distress, but their aetiology remains elusive. There are critical limitations to previous studies in this area including (i) the assessment of either apathy or impulsivity alone, despite their frequent co-existence; (ii) the assessment of behavioural changes within single diagnostic groups; and (iii) the use of limited sets of tasks or questions that relate to just one aspect of these multifactorial constructs. We proposed an alternative, dimensional approach that spans behavioural and language variants of frontotemporal dementia, progressive supranuclear palsy and corticobasal syndrome. This accommodates the commonalities of apathy and impulsivity across disorders and reveals their cognitive and anatomical bases. The ability to measure the components of apathy and impulsivity and their associated neural correlates across diagnostic groups would provide better novel targets for pharmacological manipulations, and facilitate new treatment strategies and strengthen translational models. We therefore sought to determine the neurocognitive components of apathy and impulsivity in frontotemporal lobar degeneration syndromes. The frequency and characteristics of apathy and impulsivity were determined by neuropsychological and behavioural assessments in 149 patients and 50 controls from the PIck's disease and Progressive supranuclear palsy Prevalence and INcidence study (PiPPIN). We derived dimensions of apathy and impulsivity using principal component analysis and employed these in volumetric analyses of grey and white matter in a subset of 70 patients (progressive supranuclear palsy, n = 22; corticobasal syndrome, n = 13; behavioural variant, n = 14; primary progressive aphasias, n = 21) and 27 control subjects. Apathy and impulsivity were present across diagnostic groups, despite being criteria for behavioural variant frontotemporal dementia alone. Measures of apathy and impulsivity frequently loaded onto the same components reflecting their overlapping relationship. However, measures from objective tasks, patient-rated questionnaires and carer-rated questionnaires loaded onto separate components and revealed distinct neurobiology. Corticospinal tracts correlated with patients' self-ratings. In contrast, carer ratings correlated with atrophy in established networks for goal-directed behaviour, social cognition, motor control and vegetative functions, including frontostriatal circuits, orbital and temporal polar cortex, and the brainstem. Components reflecting response inhibition deficits correlated with focal frontal cortical atrophy. The dimensional approach to complex behavioural changes arising from frontotemporal lobar degeneration provides new insights into apathy and impulsivity, and the need for a joint therapeutic strategy against them. The separation of objective tests from subjective questionnaires, and patient from carer ratings, has important implications for clinical trial design.awx101media15448041163001.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ce/5868210/b49b42ece623/awx101f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ce/5868210/af19ab853750/awx101f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ce/5868210/7f2eca0993b1/awx101f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ce/5868210/b49b42ece623/awx101f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ce/5868210/af19ab853750/awx101f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ce/5868210/7f2eca0993b1/awx101f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ce/5868210/b49b42ece623/awx101f3.jpg
摘要

冷漠和冲动是额颞叶变性常见且致残的后果。它们给照料者带来极大困扰,但其病因仍不明朗。该领域以往研究存在重大局限性,包括:(i)尽管冷漠和冲动常同时存在,但以往研究仅单独评估其中之一;(ii)仅在单一诊断组内评估行为变化;(iii)使用的任务或问题集有限,仅涉及这些多因素结构的一个方面。我们提出了一种替代性的维度方法,涵盖额颞叶痴呆、进行性核上性麻痹和皮质基底节综合征的行为和语言变体。这一方法考虑了不同疾病中冷漠和冲动的共性,并揭示了它们的认知和解剖学基础。能够跨诊断组测量冷漠和冲动的组成部分及其相关神经关联,将为药物干预提供更好的新靶点,促进新的治疗策略,并加强转化模型。因此,我们试图确定额颞叶变性综合征中冷漠和冲动的神经认知成分。通过对来自皮克病和进行性核上性麻痹患病率和发病率研究(PiPPIN)的149例患者和50例对照进行神经心理学和行为评估,确定了冷漠和冲动的频率及特征。我们使用主成分分析得出冷漠和冲动的维度,并将其用于对70例患者(进行性核上性麻痹,n = 22;皮质基底节综合征,n = 13;行为变异型,n = 14;原发性进行性失语,n = 21)和27例对照受试者的灰质和白质体积分析。尽管冷漠和冲动单独来看是行为变异型额颞叶痴呆的标准,但在各诊断组中均有出现。冷漠和冲动的测量指标常常加载到反映它们重叠关系的相同成分上。然而,客观任务、患者自评问卷和照料者自评问卷的测量指标加载到不同成分上,揭示了不同的神经生物学特征。皮质脊髓束与患者自评相关。相比之下,照料者评分与目标导向行为、社会认知、运动控制和植物功能的既定网络萎缩相关,包括额纹状体回路、眶额和颞极皮质以及脑干。反映反应抑制缺陷的成分与额叶皮质局灶性萎缩相关。针对额颞叶变性引起的复杂行为变化的维度方法,为冷漠和冲动以及针对它们的联合治疗策略的必要性提供了新的见解。将客观测试与主观问卷、患者评分与照料者评分分开,对临床试验设计具有重要意义。awx101media15448041163001。

相似文献

1
Apathy and impulsivity in frontotemporal lobar degeneration syndromes.额颞叶变性综合征中的淡漠与冲动行为
Brain. 2017 Jun 1;140(6):1792-1807. doi: 10.1093/brain/awx101.
2
White matter change with apathy and impulsivity in frontotemporal lobar degeneration syndromes.额颞叶变性综合征伴淡漠和冲动的白质改变。
Neurology. 2018 Mar 20;90(12):e1066-e1076. doi: 10.1212/WNL.0000000000005175. Epub 2018 Feb 16.
3
Transdiagnostic Network Localization of Social, Language, and Motor Symptoms in Patients With Frontotemporal Lobar Degeneration.额颞叶变性患者的社会、语言和运动症状的跨诊断网络定位。
Neurology. 2024 Dec 24;103(12):e210108. doi: 10.1212/WNL.0000000000210108. Epub 2024 Nov 25.
4
Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes.重新定义额颞叶变性综合征的多维临床表型。
Brain. 2020 May 1;143(5):1555-1571. doi: 10.1093/brain/awaa097.
5
Clinicopathological correlations in behavioural variant frontotemporal dementia.行为变异型额颞叶痴呆的临床病理相关性
Brain. 2017 Dec 1;140(12):3329-3345. doi: 10.1093/brain/awx254.
6
Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration.淡漠在额颞叶变性相关综合征中的预后意义。
Neurology. 2019 Apr 2;92(14):e1547-e1557. doi: 10.1212/WNL.0000000000007249. Epub 2019 Mar 6.
7
Predicting loss of independence and mortality in frontotemporal lobar degeneration syndromes.预测额颞叶变性综合征患者的失能和死亡风险。
J Neurol Neurosurg Psychiatry. 2021 Jul;92(7):737-744. doi: 10.1136/jnnp-2020-324903. Epub 2021 Feb 9.
8
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.额颞叶变性的组织病理学的临床和神经解剖学特征。
Brain. 2011 Sep;134(Pt 9):2565-81. doi: 10.1093/brain/awr198.
9
MRI signatures of the frontotemporal lobar degeneration continuum.额颞叶变性连续体的磁共振成像特征
Hum Brain Mapp. 2015 Jul;36(7):2602-14. doi: 10.1002/hbm.22794. Epub 2015 Mar 28.
10
GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition.额颞叶变性导致的 GABA 和谷氨酸缺失与抑制解除有关。
Brain. 2020 Dec 5;143(11):3449-3462. doi: 10.1093/brain/awaa305.

引用本文的文献

1
Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?神经退行性疾病中的去甲肾上腺素能疗法:从对症治疗到疾病修饰治疗?
Brain Commun. 2025 Aug 25;7(5):fcaf310. doi: 10.1093/braincomms/fcaf310. eCollection 2025.
2
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UK.去甲肾上腺素用于进行性核上性麻痹综合征(NORAPS):一项随机、双盲、安慰剂对照、交叉的IIb期临床试验,在英国评估口服托莫西汀治疗进行性核上性麻痹综合征患者认知和行为改变的疗效和安全性。
BMJ Open. 2025 Jul 28;15(7):e099577. doi: 10.1136/bmjopen-2025-099577.
3

本文引用的文献

1
Progression of brain atrophy in PSP and CBS over 6 months and 1 year.进行性核上性麻痹(PSP)和皮质基底节综合征(CBS)患者在6个月和1年期间脑萎缩的进展情况。
Neurology. 2016 Nov 8;87(19):2016-2025. doi: 10.1212/WNL.0000000000003305. Epub 2016 Oct 14.
2
Computational Dissection of Dopamine Motor and Motivational Functions in Humans.人类多巴胺运动和动机功能的计算剖析
J Neurosci. 2016 Jun 22;36(25):6623-33. doi: 10.1523/JNEUROSCI.3078-15.2016.
3
Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes.额颞叶变性综合征的患病率、特征及生存率
Self- versus caregiver-reported apathy across neurological disorders.神经系统疾病中自我报告与照料者报告的冷漠症状对比
Brain Commun. 2025 Jun 13;7(3):fcaf235. doi: 10.1093/braincomms/fcaf235. eCollection 2025.
4
Goal-directedness deficit in Huntington's disease.亨廷顿舞蹈症中的目标导向缺陷。
Cogn Affect Behav Neurosci. 2025 Jun 2. doi: 10.3758/s13415-025-01313-0.
5
Ageing is associated with exaggerated overstaying in foraging behaviour.衰老与觅食行为中过度停留时间延长有关。
NPJ Aging. 2025 May 30;11(1):46. doi: 10.1038/s41514-025-00240-1.
6
Cognitive and neuropsychiatric profiles distinguish atypical parkinsonian syndromes.认知和神经精神特征可区分非典型帕金森综合征。
Brain. 2025 Apr 16. doi: 10.1093/brain/awaf132.
7
Risky decision-making in dementia: exploring neural correlates and related clinical symptoms.痴呆症中的风险决策:探索神经关联及相关临床症状
Cogn Affect Behav Neurosci. 2025 Apr 11. doi: 10.3758/s13415-025-01291-3.
8
Behavioural changes in frontotemporal dementia and their cognitive and neuroanatomical correlates.额颞叶痴呆的行为变化及其认知和神经解剖学关联
Brain. 2025 Feb 12. doi: 10.1093/brain/awaf061.
9
Variable Presence of an Evolutionarily New Brain Structure Is Related to Trait Impulsivity.一种进化上新出现的脑结构的可变存在与特质冲动性有关。
Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Nov 28. doi: 10.1016/j.bpsc.2024.11.015.
10
Caregiver perspectives enable accurate diagnosis of neurodegenerative disease.照顾者的观点有助于对神经退行性疾病进行准确诊断。
Alzheimers Dement. 2025 Jan;21(1):e14377. doi: 10.1002/alz.14377. Epub 2024 Nov 19.
Neurology. 2016 May 3;86(18):1736-43. doi: 10.1212/WNL.0000000000002638. Epub 2016 Apr 1.
4
The NIMH Research Domain Criteria Initiative: Background, Issues, and Pragmatics.美国国立精神卫生研究所研究领域标准计划:背景、问题与务实做法
Psychophysiology. 2016 Mar;53(3):286-97. doi: 10.1111/psyp.12518.
5
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.运用临床和神经影像学测量方法预测托莫西汀和西酞普兰对帕金森病反应抑制的有益作用。
Hum Brain Mapp. 2016 Mar;37(3):1026-37. doi: 10.1002/hbm.23087. Epub 2016 Jan 12.
6
Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease.不同的决策缺陷损害进行性核上性麻痹和帕金森病中的反应抑制。
Brain. 2016 Jan;139(Pt 1):161-73. doi: 10.1093/brain/awv331. Epub 2015 Nov 18.
7
Apathy and noradrenaline: silent partners to mild cognitive impairment in Parkinson's disease?冷漠与去甲肾上腺素:帕金森病轻度认知障碍的隐匿伴发因素?
Curr Opin Neurol. 2015 Aug;28(4):344-50. doi: 10.1097/WCO.0000000000000218.
8
Improving response inhibition systems in frontotemporal dementia with citalopram.使用西酞普兰改善额颞叶痴呆的反应抑制系统。
Brain. 2015 Jul;138(Pt 7):1961-75. doi: 10.1093/brain/awv133. Epub 2015 May 21.
9
Dopamine enhances willingness to exert effort for reward in Parkinson's disease.多巴胺增强帕金森病患者为获得奖励而付出努力的意愿。
Cortex. 2015 Aug;69:40-6. doi: 10.1016/j.cortex.2015.04.003. Epub 2015 Apr 20.
10
Frontal white matter tracts sustaining speech production in primary progressive aphasia.原发性进行性失语症中与言语产生有关的额部白质束。
J Neurosci. 2014 Jul 16;34(29):9754-67. doi: 10.1523/JNEUROSCI.3464-13.2014.